NCT06315010
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06315010
Title REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis (REPOSE)
Acronym REPOSE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | AUT